Delivery Order SPE2DB20D1051-SPE2DB24FD7NF
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $3.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The $1,451.30 award has an ultimate completion date of April 8, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as the sole contractor. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,046.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This delivery order has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $5,102.97, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,103.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,528.49 to Amerisourcebergen Drug Corp for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has an ultimate completion date of August 1, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is providing these essential medical supplies through its corporate office division. This contract is associated with a larger Indefinite Delivery Contract (IDC) valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical product. The $3,808.17 delivery order has a completion date of February 9, 2024. AmerisourceBergen Drug Corp provides pharmaceutical products and medical supplies to the Department of Defense under an indefinite delivery contract valued up to $999,999,999.00 through December 31, 2025....
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $1,952.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This contract has an ultimate completion date of August 21, 2024 and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $10,080.39, has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to...
- The U.S. Defense Logistics Agency (DLA) awarded a $9,859.73 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 0.25-0.5 mg/dose pens. This delivery order contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Ozempic 0.25-0.5 mg/dose pens. This $30,856.15 contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. The contract is not associated with any set-aside designations. AmerisourceBergen Drug Corp also holds...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD7NFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. The contract, valued at $3,071.16, has a period of performance through March 29, 2024 and was not set-aside. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 6/27/24, 10:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 3/28/24 |